Cerapedics Print Logo

Upcoming Events

 

In the News

 

November 23, 2015

Cerapedics: A PMA First Opens New Opportunities in Cervical Spine Osteobiologics  More

 

November 3, 2015

Cerapedics Receives FDA Approval for i-FACTOR™ Peptide Enhanced Bone Graft in Cervical Spine Surgery More

 

June 16, 2015

Cerapedics Announces FDA Advisory Committee Panel Is Not Required for i-FACTOR™ PMA Approval More

 

April 7, 2015

Cerapedics Announces Closing of Loan and Equity Financing More

 

January 14, 2015

Cerapedics Receives CE Mark and TGA Listing for New i-FACTOR™ Flex FR Biologic Bone Graft More

 

September 4, 2014

Cerapedics Files Premarket Approval Application With US FDA for I-Factor™ Peptide Enhanced Bone Graft  More

 

April 14, 2014

Cerapedics Announces Closing Of Venture Debt Loan From GE Capital  More

 

March 11, 2014

Cerapedics Announces Positive Results From IDE Clinical Trial  More

 

March 4, 2014

Cerapedics to present preliminary outcomes data from i-FACTOR™ Bone Graft Study at Canaccord Genuity Musculoskeletal Conference  More

 

April 13, 2013

Cerapedics Appoints Glen A. Kashuba as Chief Exectutive Officer and Jeffrey G. Marx, PhD as President and Chief Operating Officer More

 

March 12, 2013

Cerapedics Adds New Board Member Antony Koblish More

March 4, 2013

Cerapedics Announces 10,000th Patient Treated With i-FACTOR™ Peptide Enhanced Bone Graft More

December 12, 2012

Cerapedics Secures $19 Million Series C
Financing
More

November 9, 2011

Cerapedics granted patent protecting the method of manufacture for i-FACTOR™ biologic bone graft in Lyophilized forms. More

June 30, 2010

i-FACTOR Flex Receives CE Mark. Cerapedics announced that it received the CE Mark for its i-FACTOR™ Flex bone graft product line. More



Media Inquiries

For more information, the press is invited to contact Cerapedics at info@cerapedics.com